On March 11, 2020 Biocare Medical ("Biocare"), a leading developer of world class immunohistochemistry ("IHC") and molecular reagents and instrumentation, is reported that Luis de Luzuriaga has joined the company as Chief Executive Officer (Press release, Biocare Medical, MAR 11, 2020, View Source [SID1234555424]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Mr. de Luzuriaga has spent his entire career in commercial and executive leadership roles within the life sciences tools and diagnostics sector. Notably, Mr. de Luzuriaga spent six years leading Global Commercial Operations at Leica Biosystems and also served as the Divisional Vice President and General Manager of Abbott Hematology. Most recently, Mr. de Luzuriaga was the CEO of BIT Group (subsidiary of Messer Group), a leading product development and contract manufacturer for high performance clinical, medical and life science devices.
Mr. de Luzuriaga’s proven ability to drive extraordinary growth and industry leadership within the life sciences tools sector aligns well with Biocare’s strong growth trajectory and reputation for quality diagnostic tools focused on the oncology and immunotherapy markets. "Since our first interaction with Luis, it was clear that he had the experience, capabilities and expertise to propel Biocare to the forefront of the industry," said Ryan Glaws, Partner at Excellere Partners. "His extensive experience and impressive track record at Leica, Abbott and BIT make him the ideal partner to guide Biocare through this exciting and transformational period in the company’s history."
"I am excited to join Biocare and work with what I know to be both a dynamic and talented team. Having previously competed against Biocare, I know first-hand about the quality of the products and reputation in the marketplace. It is an honor and a privilege to lead this organization, and I am very excited about the future of Biocare," said Mr. de Luzuriaga.